1h Free Analyst Time
The exosome therapeutics market is forecasted to grow by USD 234.7 million during 2023-2028, accelerating at a CAGR of 16.19% during the forecast period. The report on the exosome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, potential of exosomes in personalized medicine, and rising research on exosome therapeutics.
The exosome therapeutics market is segmented as below:
By Application
- Cancer therapies
- Autoimmune diseases
- Infectious diseases
- Others
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the exosome therapeutics market covers the following areas:
- Exosome therapeutics market sizing
- Exosome therapeutics market forecast
- Exosome therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Technavio Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by Distribution Channel
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global exosome therapeutics market: Aegle Therapeutics, Aethlon Medical Inc., AMS Biotechnology Europe Ltd., Bio Techne Corp., Capital Biosciences Inc., Capricor Therapeutics Inc., CILOA SAS, Creative Biolabs, Cytiva, Everzom, Evotec SE, Evox Therapeutics Ltd., ExoCoBio Co. Ltd., Inoviq Ltd., Lonza Group Ltd., NanoFCM Co., Ltd, Regeneron Pharmaceuticals Inc., ReNeuron Group plc, The ExoBiologics Co., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advanced technology in exosome collection."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aegle Therapeutics
- Aethlon Medical Inc.
- AMS Biotechnology Europe Ltd.
- Bio Techne Corp.
- Capital Biosciences Inc.
- Capricor Therapeutics Inc.
- CILOA SAS
- Creative Biolabs
- Cytiva
- Everzom
- Evotec SE
- Evox Therapeutics Ltd.
- ExoCoBio Co. Ltd.
- Inoviq Ltd.
- Lonza Group Ltd.
- NanoFCM Co. Ltd
- Regeneron Pharmaceuticals Inc.
- ReNeuron Group plc
- The ExoBiologics Co.
- Thermo Fisher Scientific Inc.
